Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-08-12 Equity Swap | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 31,933,334 | $0 | 0 (Indirect) | View |
| 2022-08-12 Disposition | 2022-08-16 6:55 pm | N/A N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 17,054 | $0 | 0 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 2032-05-16 | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 41,006 | $0.56 | 31,980,464 (Direct) | View |
| 2022-05-17 Option Award | 2022-05-19 6:01 pm | 2023-05-17 N/A | Epizyme Inc. | EPZM | Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 8,994 | $0 | 31,980,464 (Direct) | View |
Ownership | 2022-02-09 4:30 pm | N/A N/A | Epizyme Inc. | EPZM | Royalty Pharma Investments 2019 ICAV Director 10% Owner | 0 | $0 | 22,666,667 (Direct) | View |